Republican U.S. Rep. Chris Collins says he will no longer run for re-election after being charged with insider trading.
By Karen Matthews, Associated Press
In our news wrap Wednesday, New York Republican Rep. Chris Collins and his son are under indictment for alleged insider trading. Prosecutors say his son dumped stock in a pharmaceutical company after Collins alerted him that an experimental drug had…
When Australian biotech firm Innate Immunotherapeutics needed to raise money last summer, it offered a sweetheart deal to “sophisticated U.S. investors.” One of them was Rep. Tom Price.
By Jay Hancock and Rachel Bluth, Kaiser Health News
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.